Post by
mingzhu on Apr 29, 2022 11:07pm
financials: loss of 15.9m, revenue 497k, gross margin 13%
cash 1.9m on hand by 2021. It should be nearly spent now.
Comment by
mingzhu on May 01, 2022 5:30pm
at 0.06, 3.7m/0.06= 61m shares to be issued at market price +current 96m = 157m . i am waiting for Q1 financials to see how much expense it will have for a Q to calculate how long it can surviive before BK. It is very risky now. The only thing valuable is the patented tech
Comment by
lscfa on May 01, 2022 8:55pm
Dec. 2, 2021 - Atmofizer Technologies Inc. is pleased to announce that the Company has entered into a non-exclusive distribution agreement with USA Rapid Test, LLC under which USA Rapid Test has placed an initial purchase order for US$4.2 million personal space, Atmofizer A500s.